Plecanatide is a Guanylate Cyclase-C Agonist. The mechanism of action of plecanatide is as a Guanylate Cyclase Activator. Plecanatide is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC). It is grouped under the following drug class(es): Peptides. Its therapeutic use is listed as laxatives. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Trulance, Guanilib and plecanatida. Its PubChem CID is 70693500.
Plecanatide
| CAS No | 467426-54-6 |
|---|---|
| Molecular Formula | C65H104N18O26S4 |
| Molecular Weight | 1681.9 g/mol |
| Synonyms | (2S)-2-[[(1R,4S,7S,10S,13S,16R,19S,22S,25R,32S,38R)-10-(2-amino-2-oxoethyl)-25-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]propanoyl]amino]butanoyl]amino]-22-(2-carboxyethyl)-32-[(1R)-1-hydroxyethyl]-4-methyl-19-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36-undecaoxo-7,13-di(propan-2-yl)-27,28,40,41-tetrathia-2,5,8,11,14,17,20,23,31,34,37-undecazabicyclo[14.13.13]dotetracontane-38-carbonyl]amino]-4-methylpentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Plecanatide is a Guanylate Cyclase-C Agonist. The mechanism of action of plecanatide is as a Guanylate Cyclase Activator. Plecanatide is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC).
The listed CAS number is 467426-54-6.
The listed molecular formula is C65H104N18O26S4.
The listed molecular weight is 1681.9 g/mol.
The source lists Trulance, Guanilib and plecanatida.
Its therapeutic use is listed as laxatives.